Compare SST & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SST | COSM |
|---|---|---|
| Founded | 2013 | 2009 |
| Country | United States | United States |
| Employees | 250 | N/A |
| Industry | Diversified Commercial Services | Other Pharmaceuticals |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.9M | 13.5M |
| IPO Year | N/A | 2009 |
| Metric | SST | COSM |
|---|---|---|
| Price | $3.69 | $0.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 6.3M | 313.7K |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $54,426,402.00 |
| Revenue This Year | N/A | $20.69 |
| Revenue Next Year | N/A | $53.10 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.97 |
| 52 Week Low | $0.29 | $0.28 |
| 52 Week High | $11.30 | $1.32 |
| Indicator | SST | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 57.97 | 32.20 |
| Support Level | $3.55 | $0.30 |
| Resistance Level | $4.54 | $0.50 |
| Average True Range (ATR) | 1.00 | 0.03 |
| MACD | 0.29 | 0.00 |
| Stochastic Oscillator | 56.18 | 24.87 |
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It operate several flagship brands across multiple consumer verticals, including shopping, travel and search, and a customer acquisition and marketing platform powered by Artificial Intelligence and machine learning. The company's segment includes Marketing and Products. It generates maximum revenue from the Marketing segment. Geographically, it operates in United States and Other countries.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.